»

DrugPatentWatch

DrugPatentWatch Archives

You are currently viewing the 2009 archives
Click here to return to the current data set

DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,400 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices.

Patent: 5,214,052

Summary for Patent: 5,214,052

Title: Method for dissolving arginineamides and pharmaceutical compositions containing them
Abstract:A method for dissolving an arginineamide of the invention comprising dissolving N.sup.2 -arylsulfonyl-L-arginineamide having the general formula (I) ##STR1## wherein R.sup.1 represents a (2R, 4R)-4-alkyl-2-carboxypiperizino group and R.sup.2 represents a phenyl group or a condensed polycyclic compound residue which may be substituted with one or more substituents selected from lower alkyl groups, lower alkoxy groups and lower alkyl-substituted amino groups, said condensed polycyclic compound residue including a benzene ring which binds to sulfur atom of the sulfonyl group in the general formula (I) and is condensed with one or more other rings which may be heterocyclic and having 7 to 14 carbon atoms as the ring-constituent atoms; and/or its salt in a solvent of alcohol and water is disclosed herein. And, the pharmaceutical composition comprising N.sup.2 -arylsulfonyl-L-arginineamide having the general formula (I), an alcohol and water is disclosed herein.
Inventor(s): Ofuchi; Kunihiko (Hasaki, JP), Nomura; Tatsuo (Hasaki, JP)
Assignee: Mitsubishi Kasei Corporation (Tokyo, JP)
Application Number:07/851,248
Patent Claim Types:
see list of patent claims
Use; Compound; Composition;
Patent PDF download available with subscription

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Product Substance Delist_Flag Patent Expiration Patented / Exclusive Use
Pfizer
ARGATROBAN
argatroban
INJECTABLE; INJECTION020883Jun 30, 2000RXYes5,214,052<disabled>
The preview shows a limited data set. Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 5,214,052

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan62-188484Jul 28, 1987

International Patent Family for Patent: 5,214,052

Country Document Number Publication Date
Germany122005000056Feb 23, 2006
Germany3866303Jan 02, 1992
European Patent Office0301970Feb 01, 1989
JapanH0576929Oct 25, 1993
The preview shows a limited data set. Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.


« Back to Dashboard

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Sign up for a free trial

No commitment, no credit card required
First name
Last name
Email address

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639


`abc